Cargando…
The Effects of Armillarisin A on Serum IL-1β and IL-4 and in Treating Ulcerative Colitis
To study the therapeutic effect of Armillarisin A on patients with ulcerative colitis (UC) and on serum IL-1β and IL-4, sixty patients with UC were randomly divided into three groups: Armillarisin A treatment group (Group I), Armillarisin-combined hormone therapy group (Group II), and hormones treat...
Autores principales: | Wu, Ping, Guo, Yonggao, Jia, Fangyuan, Wang, Xiuli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457911/ https://www.ncbi.nlm.nih.gov/pubmed/25420534 http://dx.doi.org/10.1007/s12013-014-0413-7 |
Ejemplares similares
-
Prognostic value of assessment of stool and serum IL-1β, IL-1ra and IL-6 concentrations in children with active and inactive ulcerative colitis
por: Wędrychowicz, Andrzej, et al.
Publicado: (2017) -
IL23 as a novel serum based biomarker in ulcerative colitis- an editorial
por: Chakraborty, Subhankar
Publicado: (2012) -
Serum IL-13 Predicts Response to Golimumab in Bio-Naïve Ulcerative Colitis
por: Kinoshita, Naohiko, et al.
Publicado: (2022) -
Possible role of microRNA miRNA-IL-25 interaction in mice with ulcerative colitis
por: Yao, Jun, et al.
Publicado: (2020) -
Protective effect of TSLP and IL-33 cytokines in ulcerative colitis
por: Tahaghoghi-Hajghorbani, Sahar, et al.
Publicado: (2019)